Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-23-002778
Date:2023-01-06
Issuer: CINCOR PHARMA, INC. (CINC)
Original Submission Date:

Reporting Person:

ALLISON DAVID D.
C/O CINCOR PHARMA, INC.
230 THIRD AVENUE, 6TH FLOOR WALTHAM, MA 02451

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 11.78 2023-01-06 deemed execution date A 1,499 (a) 2023-01-06 2033-01-05 common stock 1,499 $11.78 1,499 direct
Footnotes
IDfootnote
f1 this option was issued to the reporting person pursuant to the issuer's non-employee director compensation policy in lieu of retainer fees of $12,500.
WhaleWisdom Logo

Elevate your investments